Evidence map›Paper›PMID 41155198›Full record

ArticleInternational journal of molecular sciences2025

The Importance of Molecular Size, Concentration, and Thermal Conditions in Enhancing Lignin Derivatives' Interactions with Skin-like Membranes: Implications for Cosmetic and Therapeutic Applications.

Alexandra Farcas, Alex-Adrian Farcas, Lorant Janosi

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alexandra FarcasNational Institute for Research and Development of Isotopic and Molecular Technologies, 67-103 Donat, 400293 Cluj-Napoca, Romania.
Alex-Adrian FarcasNational Institute for Research and Development of Isotopic and Molecular Technologies, 67-103 Donat, 400293 Cluj-Napoca, Romania.ORCID 0000-0002-9207-8520
Lorant JanosiNational Institute for Research and Development of Isotopic and Molecular Technologies, 67-103 Donat, 400293 Cluj-Napoca, Romania.ORCID 0000-0001-8747-1339

Funding

UEFISCDI - Executive Agency for Higher Education, Research, Development and Innovation Funding project no. 61TE, code PN-IV-P2-2.1-TE-2023-0300
6 · The paper itself

Abstract

Lignin is one of the most abundant natural biopolymers and plays a crucial role in the development of safe and sustainable alternatives for healthcare products. In this study, we employed molecular dynamics simulations and free energy calculations to investigate lignin derivatives' interactions with skin-like membranes. Specifically, we designed a small lignin derivative composed of syringyl and guaiacyl subunits. Our results reveal that molecular size, concentration, and thermal conditions critically influence the insertion, interaction dynamics, and localization behavior of lignin derivatives. Notably, variations in these parameters induce distinct behaviors, including rapid membrane insertion, hydrogen bonding, clustering, and surface adhesion. The findings provide insights into the molecular mechanisms governing lignin derivatives' interactions with skin-like membranes, with implications for developing bio-based skincare formulations and transdermal delivery systems. Our results highlight the importance of molecular size and concentration in optimizing lignin-derived compounds for dermatological and therapeutic applications.

Indexed as

CosmeticsLigninSkinHumansHydrogen BondingMolecular Dynamics SimulationMolecular WeightTemperatureCosmeticsLignincosmetic applicationsfree energy calculationsligninmolecular dynamicsskin membranes

Identifiers

PMID41155198
PMCPMC12564135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.